Bilateral primary adrenal lymphoma successfully treated with non-CHOP chemotherapy regimen

Anshul Singh, Karthik Udupa, Sharath P. Madhyastha, Swati Sharma

Research output: Contribution to journalArticle

Abstract

Primary bilateral non-Hodgkin's lymphoma of the adrenal gland is a rare presentation with <200 reported cases. We report a 70-year-old man who presented with vomiting and abdominal pain for 2 weeks and was subsequently diagnosed to have high-grade lymphoma of the adrenal glands. The patient was then started on a rituximab-bendamustine chemotherapy regimen. The patient tolerated treatment well without significant side effects. Repeat positron emission tomography CT scan after four cycles of chemotherapy showed complete response. The patient has completed six cycles of chemotherapy and is on regular follow-up with no signs of relapse.

Original languageEnglish
Article numberbcr-2017-223078
JournalBMJ Case Reports
Volume2018
DOIs
Publication statusPublished - 01-01-2018

Fingerprint

Lymphoma
Adrenal Glands
Drug Therapy
Non-Hodgkin's Lymphoma
Positron-Emission Tomography
Abdominal Pain
Vomiting
Recurrence
Therapeutics
Bendamustine Hydrochloride
Rituximab

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Singh, Anshul ; Udupa, Karthik ; Madhyastha, Sharath P. ; Sharma, Swati. / Bilateral primary adrenal lymphoma successfully treated with non-CHOP chemotherapy regimen. In: BMJ Case Reports. 2018 ; Vol. 2018.
@article{f48e50103e59408a9a838c33f1e2ef55,
title = "Bilateral primary adrenal lymphoma successfully treated with non-CHOP chemotherapy regimen",
abstract = "Primary bilateral non-Hodgkin's lymphoma of the adrenal gland is a rare presentation with <200 reported cases. We report a 70-year-old man who presented with vomiting and abdominal pain for 2 weeks and was subsequently diagnosed to have high-grade lymphoma of the adrenal glands. The patient was then started on a rituximab-bendamustine chemotherapy regimen. The patient tolerated treatment well without significant side effects. Repeat positron emission tomography CT scan after four cycles of chemotherapy showed complete response. The patient has completed six cycles of chemotherapy and is on regular follow-up with no signs of relapse.",
author = "Anshul Singh and Karthik Udupa and Madhyastha, {Sharath P.} and Swati Sharma",
year = "2018",
month = "1",
day = "1",
doi = "10.1136/bcr-2017-223078",
language = "English",
volume = "2018",
journal = "BMJ Case Reports",
issn = "1757-790X",
publisher = "BMJ Publishing Group",

}

Bilateral primary adrenal lymphoma successfully treated with non-CHOP chemotherapy regimen. / Singh, Anshul; Udupa, Karthik; Madhyastha, Sharath P.; Sharma, Swati.

In: BMJ Case Reports, Vol. 2018, bcr-2017-223078, 01.01.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Bilateral primary adrenal lymphoma successfully treated with non-CHOP chemotherapy regimen

AU - Singh, Anshul

AU - Udupa, Karthik

AU - Madhyastha, Sharath P.

AU - Sharma, Swati

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Primary bilateral non-Hodgkin's lymphoma of the adrenal gland is a rare presentation with <200 reported cases. We report a 70-year-old man who presented with vomiting and abdominal pain for 2 weeks and was subsequently diagnosed to have high-grade lymphoma of the adrenal glands. The patient was then started on a rituximab-bendamustine chemotherapy regimen. The patient tolerated treatment well without significant side effects. Repeat positron emission tomography CT scan after four cycles of chemotherapy showed complete response. The patient has completed six cycles of chemotherapy and is on regular follow-up with no signs of relapse.

AB - Primary bilateral non-Hodgkin's lymphoma of the adrenal gland is a rare presentation with <200 reported cases. We report a 70-year-old man who presented with vomiting and abdominal pain for 2 weeks and was subsequently diagnosed to have high-grade lymphoma of the adrenal glands. The patient was then started on a rituximab-bendamustine chemotherapy regimen. The patient tolerated treatment well without significant side effects. Repeat positron emission tomography CT scan after four cycles of chemotherapy showed complete response. The patient has completed six cycles of chemotherapy and is on regular follow-up with no signs of relapse.

UR - http://www.scopus.com/inward/record.url?scp=85051590435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051590435&partnerID=8YFLogxK

U2 - 10.1136/bcr-2017-223078

DO - 10.1136/bcr-2017-223078

M3 - Article

VL - 2018

JO - BMJ Case Reports

JF - BMJ Case Reports

SN - 1757-790X

M1 - bcr-2017-223078

ER -